Carregant...
Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma
Systemic therapy strategies in the setting of localized and locally advanced renal cell carcinoma (RCC) have continued to evolve in two directions: as adjuvant therapy (to reduce risk of recurrence or progression in high risk localized groups), or as neoadjuvant therapy as a strategy to render prima...
Guardat en:
| Publicat a: | J Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463563/ https://ncbi.nlm.nih.gov/pubmed/31057615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7309205 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|